CCL20



CCL20

S1SS1N2NN2F3FF3D4DD4C5CC5C6CC6L7LL7T8TT8Y9YY9T10TT10K11KK11N12NN12V13VV13Y14YY14H15HH15H16HH16A17AA17R18RR18N19NN19F20FF20V21VV21G22GG22F23FF23T24TT24T25TT25Q26QQ26M27MM27A28AA28D29DD29E30EE30A31AA31C32CC32D33DD33I34II34N35NN35A36AA36I37II37I38II38F39FF39H40HH40L41LL41K42KK42S43SS43K44KK44R45RR45S46SS46V47VV47... and 23 more residue(s)...... and 23 more residue(s)

SMILES None
InChIKey None
Sequence SNFDCCLTYTKNVYHHARNFVGFTTQMADEACDINAIIFHLKSKRSVCADPKQIWVKRILHLLSLRTKKM

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

CCL20

S1SS1N2NN2F3FF3D4DD4C5CC5C6CC6L7LL7T8TT8Y9YY9T10TT10K11KK11N12NN12V13VV13Y14YY14H15HH15H16HH16A17AA17R18RR18N19NN19F20FF20V21VV21G22GG22F23FF23T24TT24T25TT25Q26QQ26M27MM27A28AA28D29DD29E30EE30A31AA31C32CC32D33DD33I34II34N35NN35A36AA36I37II37I38II38F39FF39H40HH40L41LL41K42KK42S43SS43K44KK44R45RR45S46SS46V47VV47... and 23 more residue(s)...... and 23 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.